← All diseases
Muscles and connective tissue
Duchenne muscular dystrophy
Would you like to receive a message when there is new research on Duchenne muscular dystrophy? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was studied — and you'll get notified as soon as there's new research on Duchenne muscular dystrophy. View what Premium costs.
Publications and studies (1744)
- Examining the emotional impact and financial strain on caregivers of those with Duchenne muscular dystrophy in Saudi Arabia: findings from a questionnaire-based cross-sectional study. (2026/06/18) ♡
- Changes in Bone Parameters and Serum Zinc Levels Following Oral Zinc Supplementation in Duchenne Muscular Dystrophy: A Quasi-Experimental Study. (2026/06/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Multi-System Roles of Dp71 Dystrophin Isoforms in Duchenne Muscular Dystrophy. (2026/06/11) ♡
- Influencing factors and early warning indicators for nonvertebral fractures in patients with Duchenne muscular dystrophy. (2026/06/11) ♡
- High-throughput discovery of arginine-depleted peptides enables effective antisense delivery for Duchenne muscular dystrophy. (2026/06/10) ♡
- 15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss. (2026/06/09) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Bacteroides-derived endocannabinoid-like commendamide attenuates skeletal muscle ferroptosis in vitro: implications for Duchenne muscular dystrophy. (2026/06/06) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effectiveness of telerehabilitation on motor and respiratory function in duchenne muscular dystrophy: a systematic review and meta-analysis. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multifaceted Assessment of Nutritional Status and Gastrointestinal Health in Duchenne Muscular Dystrophy: Approaches Based on Skinfold Thickness and Mid-Upper Arm Circumference. (2026/06/01) ♡
- Voluntary wheel running combined with low-dose lithium supplementation improves novel object recognition in male DBA/2 J mdx mice. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. RNA Therapeutics Targeting Skeletal Muscle: Emerging Antisense and Gene-Modifying Strategies. (2026/05/28) ♡
- U.S. health plan coverage of Neuromuscular Disease Therapies: An assessment of policy availability and restrictions. (2026/05/01) ♡
- Change in respiratory outcomes in adults with Duchenne muscular dystrophy in the era of corticosteroids. (2026/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Yoga as an Adjunctive Intervention for Duchenne Muscular Dystrophy: A Scoping Review. (2026/05/01) ♡
- Quality Improvement to Promote Advance Care Planning for Young Adults with Duchenne Muscular Dystrophy. (2026/04/21) ♡
- Transgene-induced cardiotoxicity in high-dose AAV gene transfer. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bladder dysfunction in Duchenne muscular dystrophy: A narrative review. (2026/04/01) ♡
- Longitudinal ankle range of motion and functional decline in Duchenne muscular dystrophy. (2026/04/01) ♡
- Conjugated Antisense Oligonucleotides for Skipping of Duchenne Muscular Dystrophy Exon 53: A Cautionary Study. (2026/04/01) ♡
- Orphan Drugs and Diseases: A Systematic Review. (2026/04/01) ♡
- CTRP1 regulates skeletal muscle differentiation through quality control of mitochondrial dynamics and function. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Obestatin: canonical and unexpected functions. (2026/04/01) ♡
- Metabolic Complications and Ultrasound-Detected Liver Abnormalities in Paediatric Patients With Duchenne Muscular Dystrophy. (2026/04/01) ♡
- Survey of Adrenal Insufficiency Management for Duchenne muscular dystrophy in Italy. (2026/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Sarcoglycanopathy with absent expression of all sarcoglycan proteins in a young cat with clinical features of feline hypertrophic muscular dystrophy. (2026/04/01) ♡
- Targeting Skeletal Muscle in Duchenne Muscular Dystrophy: Integrating in Silico and Experimental Approaches to Sodium-Glucose Cotransporter-2 Inhibition. (2026/03/01) ♡
- Quantitative Magnetic Resonance Imaging of Gluteal Muscle Groups Detects Stage-Specific Progression and Early-Stage Damage in Duchenne Muscular Dystrophy: A 12-Month Longitudinal Study. (2026/03/01) ♡
- Acute Adverse Events Following Intravenous Bisphosphonate Infusion Are Uncommon in Patients With Duchenne Muscular Dystrophy Previously Treated With Oral Bisphosphonates. (2026/03/01) ♡
- Environmental Determinants of Participation in Children With Duchenne Muscular Dystrophy. (2026/03/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Height, weight, and body mass index trajectories and their correlation with functional outcome assessments in boys with Duchenne muscular dystrophy. (2026/03/01) ♡
- Meeting report: Expanding access to advanced cardiac therapies, including ventricular assist devices (VADs) and heart transplantation in muscular dystrophy. (2026/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. ALT/CK Ratio as an Early Marker of Liver Injury After Gene Therapy in Duchenne Muscular Dystrophy. (2026/03/01) ♡
- Beta-nicotinamide mononucleotide attenuates creatine kinase release in Duchenne muscular dystrophy model rats. (2026/02/01) ♡
- Reply to the letter to the editor "Gene therapy advancements in Duchenne muscular dystrophy: Overlooked challenges". (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015-2025). (2026/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy of Zoledronic Acid on Bone Mineral Density in Boys With Duchenne Muscular Dystrophy: A Prospective Observational Study. (2026/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Six-Minute Activity-95(th) Centile, a Novel Wearable-Derived Clinical Outcome Assessment for Duchenne Muscular Dystrophy. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Duchenne Muscular Dystrophy: Clinical Innovations, Ethical Considerations, and Evolving the Path to Adulthood. (2026/02/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. HDAC11 deficiency improves muscle phenotype in a Duchenne muscular dystrophy murine model by reducing inflammation and fibrosis. (2026/02/01) ♡
- Long-Term Safety and Efficacy of Systemic DT-DEC01 Cell Therapy in Non-Ambulatory Duchenne Muscular Dystrophy Patients: a 24-Month Clinical Evaluation. (2026/02/01) ♡
- β-Hydroxy-β-methylbutyrate enhances fast-twitch muscle and mitochondrial function, histopathology and mTORC1 signalling in the mdx dystrophic mouse. (2026/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Becker muscular dystrophy (BMD) is caused by a dystrophin missense mutation in the original family of Becker and Kiener. (2026/02/01) ♡
- Age-related differences in hot and cold executive functions in boys with Duchenne muscular dystrophy: longitudinal individual changes and age-group comparisons across childhood and adolescence. (2026/02/01) ♡
- The Balancing Act of Paid Work and Caregiving in Duchenne Muscular Dystrophy (DMD): Results from a Cross-sectional Survey. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The complexity of dystrophin transcription and processing: implications of transcript imbalance on dystrophin gene targeting strategies. (2026/02/01) ♡
- Knock-out of specific DMD gene isoforms in the parental hESC line SA001 using CRISPR/Cas9. (2026/02/01) ♡
- [Chinese expert consensus on the diagnosis and treatment of Becker muscular dystrophy]. (2026/02/01) ♡
- Direct AMPK Activation Confers Mutation-Independent Therapeutic Benefit in Duchenne Muscular Dystrophy. (2026/02/01) ♡
- Voluntary running sustains the correction of inflammation-related gene expression conferred by AAV gene therapy in mdx mice. (2026/01/29) ♡
- Muscle satellite cell editing by LNP-CRISPR-Cas9 to resist muscle injury. (2026/01/27) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.